Hold Advanced Enzyme Technologies; target of Rs 300: ICICI Direct

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

ICICI Direct's research report on Advanced Enzyme Technologies

Advanced Enzyme Technologies (AET) is a focused, research driven Indian enzymes company with a product basket of 400+ proprietary products developed from 68 indigenous enzymes and probiotics. The business is divided into three segments - 1) human healthcare, 2) animal healthcare and 3) industrial processing business • It has nine manufacturing and seven R&D facilities, which consist of three integrated fermentations, recovery & formulation facilities, one extraction and recovery facility and one satellite blending, mixing & formulation facility.

Outlook

We upgrade the stock from REDUCE to HOLD with a neutral stance as we wait for 1) consistency in core businesses 2) improvement in margin profile. We value AET at Rs 300 i.e. 22x FY24E EPS of Rs 13.6.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Advanced Enzyme Technologies - 23 -11-2022 - icici